Key result
Extracardiac Fontan with Contegra conduit carries ~11% operative mortality with favorable midterm survival.
Why the study?
Constructing a competent valve using the xenograft valved conduit (Contegra) in the extracardiac Fontan connection may maintain better forward flow into the pulmonary circulation.
Does the Contegra conduit provide safe and effective outcomes in patients undergoing extracardiac Fontan connection?
Population
18 patients undergoing extracardiac Fontan connection, median age 4.5 years (range 2.5-34 years)
Comparison
Extracardiac Fontan connection using Contegra conduit (bovine valved xenograft)
Design
Retrospective observational review
Follow-up
Mean 15.8 months (range 8-48 months)
Authors
Loading...
May support Contegra as Fontan conduit option; leaves open need for larger comparative studies before wider adoption.
Observational (n=18)
Does the Contegra conduit provide safe and effective outcomes in patients undergoing extracardiac Fontan connection?
The Contegra xenograft is a potential alternative conduit for extracardiac Fontan connections, demonstrating encouraging preliminary results with good conduit patency and oxygen saturation.
Ghassan M. Baslaim (2008) conducted an observational in Extracardiac Fontan connection (n=18). Contegra conduit (bovine valved xenograft) was evaluated on Operative mortality. Extracardiac Fontan connection using the Contegra conduit resulted in an 11% operative mortality rate, with all surviving patients remaining asymptomatic at a mean follow-up of 15.8 months.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: